GRDN · Guardian Pharmacy Services, Inc.
$39.48
-1.03 (-2.53%)
At close · Aug 6
Market Cap
$2.50B
Shares
63.32M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$40.50
Open$40.17
Day$40.17–41.11
52W$19.30–44.00
Avg vol 30d381K
Short int2.8M · 4.4% float · 7.1d
Short vol44%
Last earningsAug 6, 2026
DataSep 2024–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+17%
above
Price vs 50-day avg
−0%
below
RSI (14)
50
neutral
MACD trend
Negative
52-week position
86%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+17%
trailing
YTD return
+35%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $41 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
44 of 170 funds reported for Jun 30 · net +719.0K sh shares · +12 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.41% of float · ▼ -9.6% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
170 holders — near 1-yr high, broad support
Squeeze score
63
elevated · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
Gross margin
20%
expanding
Balance sheet
$65.6M
net cash
Quant / Vol
risk profile
Volatility
42%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
4.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Revenue
· FY 2026
Raised
$1.43B – $1.45B
prior FY $1.45B
midpoint −0.6% Y/Y
Adjusted EBITDA
· FY 2026
Non-GAAP
Raised
$129M – $131M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+17%
Bullish
Price vs 50-day avg
−0%
Neutral
RSI (14)
50
Neutral
MACD trend
Negative
Bearish
52-week position
86%
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $41 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
44 of 170 funds reported for Jun 30 · net +719.0K sh shares · +12 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.41% of float · ▼ -9.6% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
170 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $19
Now $41 · 86%
52-wk high $44
vs 200-day avg +17%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $29.7M | second quarter ended June 30, 2026 | — |
|
|
|||
| Full-service pharmacies | 54 | as of June 30, 2026 | — |
| Licensed pharmacies | 61 | as of June 30, 2026 | +0.0% |
|
|
|||
| Residents served | 210,000 | second quarter ended June 30, 2026 | — |
|
|
|||
| Adjusted EPS non-GAAP | $0.37 | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRDN
this stock
Guardian Pharmacy Services, Inc.
|
$2.50B | +34.6% | — | — | 4.4% |
|
HCA
HCA Healthcare, Inc.
|
$90.71B | -11.9% | +7.1% | 14.1 | 2.6% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.50B | -2.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.08B | +31.7% | -2.3% | 10.1 | 3.7% |
|
FMS
Fresenius Medical Care AG
|
$12.83B | +4.3% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRDN | -1.2% | +0.3% | +17.1% | +2.5% | +34.6% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -6.7% | -3.0% | +5.8% | -0.6% | +21.7% |
Key facts
CIK
1802255
CUSIP
40145W101
13F (30d)
44 filings
42 filers
Visit website
Investor relations